All terms
IMDRF
International Medical Device Regulators Forum.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026
Definition
IMDRF is a voluntary group of medical device regulators that work together to harmonize medical device regulation globally, building on the foundation of the Global Harmonization Task Force (GHTF). Members include regulators from Australia, Brazil, Canada, China, the EU, Japan, Russia, Singapore, South Korea, the UK and the US, with the WHO as an official observer. It succeeded GHTF in 2011. Its documents on Software as a Medical Device, MDSAP, adverse event terminology and cybersecurity are widely referenced in national rules and guidance. What the regulation says
The International Medical Device Regulators Forum (IMDRF) aims to accelerate international medical device regulatory harmonization and convergence. Its work products, such as guidance documents, inform regulatory approaches worldwide, for instance influencing the FDA's perspective on specific topics or serving as foundational principles for the EU Medical Device Regulation (MDR) where applicable. While not a regulatory body itself, its consensually developed guidance can be adopted or adapted by national regulators.What this means in practice
Many widely adopted concepts - SaMD risk categorization, MDSAP, UDI principles - originated in IMDRF working groups.Examples
- A manufacturer designing a new Software as a Medical Device (SaMD) could consult IMDRF guidance on SaMD risk categorization to anticipate regulatory expectations in multiple markets.
- A company seeking to expand into several countries might utilize the Medical Device Single Audit Program (MDSAP), an IMDRF initiative, to streamline their audit process across participating jurisdictions.
- When developing unique device identification (UDI) systems, a manufacturer would refer to IMDRF principles that underpin UDI requirements globally, including those in the EU MDR and by the FDA.
Common pitfalls
- •A common pitfall is misunderstanding IMDRF documents as legally binding regulations rather than voluntary guidance.
- •Another mistake is assuming immediate, universal adoption of all IMDRF guidance by every national regulator.
- •Failing to recognize that IMDRF contributions often form the basis for later national or regional regulatory frameworks can lead to a lack of proactive planning.
Frequently asked questions
IMDRF succeeded the Global Harmonization Task Force (GHTF) in 2011, building on its foundational work. IMDRF has a more structured management committee and a commitment from regulators to implement harmonized guidance.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Regulatory
· Same categoryRegulatory
510(k) Premarket Notification(510(k))
FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Regulatory
510(k) Summary vs 510(k) Statement
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Regulatory
513(g) Request for Information(513(g))
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
Regulatory
Abbreviated 510(k)
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Cited by
Where this term appears across MedTech Terms.
Ecosystems (2)
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Tier 2Regulator guidance and consensus· 3
Link health: 3 verified· last checked 2026-06-20
IMDRF·1FDA·1European Commission·1
- 1IMDRFTier 2 VerifiedIMDRFimdrf.org
- 2FDA - Medical DevicesTier 2 VerifiedFDAfda.gov
- 3European Commission - Medical DevicesTier 2 VerifiedEuropean Commissionhealth.ec.europa.eu
Inline markers like [1] jump to the matching reference above.